A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

Phase

Condition

Healthy Volunteers

Treatment

PF-07976016 Formulation B

PF-07976016 Formulation A

Clinical Study ID

NCT06670170

C5541005

Ages > 18
All Genders
Accepts Healthy Volunteers

Study Summary

The primary purpose of this study is to measure and compare the amount of study drug in your blood after a single dose of two formulations of study drug.

Eligibility Criteria

Inclusion

Key Inclusion Criteria:

Overtly healthy as determined by medical evaluation including medical history,physical examination, laboratory tests, vital signs and ECG assessments.
Willing to provide consent and follow study requirements
Total body weight >110lbs (50kg)

Exclusion

Key Exclusion Criteria:

Any condition affecting drug absorption, clinically significant laboratory values
HIV, HepB & HepC
Serious illness or hospitalization, or other condition, that may increase the riskof study participation or, in the investigator's judgment, make the participantinappropriate for the study.
Use of prescription or non-prescription drugs within a specified timeframe prior tothe first dose of study intervention
positive urine drug test at screening/admission
History of alcohol abuse or repeated binge drinking and/or any other illicit druguse or dependence within 6 months of screening
Use of tobacco/nicotine containing products more than the equivalent of 5cigarettes/day or 2 chews of tobacco/day

Study Design